751 related articles for article (PubMed ID: 19765815)
1. Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial.
Gosling RD; Gesase S; Mosha JF; Carneiro I; Hashim R; Lemnge M; Mosha FW; Greenwood B; Chandramohan D
Lancet; 2009 Oct; 374(9700):1521-32. PubMed ID: 19765815
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials.
Aponte JJ; Schellenberg D; Egan A; Breckenridge A; Carneiro I; Critchley J; Danquah I; Dodoo A; Kobbe R; Lell B; May J; Premji Z; Sanz S; Sevene E; Soulaymani-Becheikh R; Winstanley P; Adjei S; Anemana S; Chandramohan D; Issifou S; Mockenhaupt F; Owusu-Agyei S; Greenwood B; Grobusch MP; Kremsner PG; Macete E; Mshinda H; Newman RD; Slutsker L; Tanner M; Alonso P; Menendez C
Lancet; 2009 Oct; 374(9700):1533-42. PubMed ID: 19765816
[TBL] [Abstract][Full Text] [Related]
3. Risks of Hemolysis in Glucose-6-Phosphate Dehydrogenase Deficient Infants Exposed to Chlorproguanil-Dapsone, Mefloquine and Sulfadoxine-Pyrimethamine as Part of Intermittent Presumptive Treatment of Malaria in Infants.
Poirot E; Vittinghoff E; Ishengoma D; Alifrangis M; Carneiro I; Hashim R; Baraka V; Mosha J; Gesase S; Chandramohan D; Gosling R
PLoS One; 2015; 10(11):e0142414. PubMed ID: 26599634
[TBL] [Abstract][Full Text] [Related]
4. Effect of intermittent preventive treatment for malaria during infancy on serological responses to measles and other vaccines used in the Expanded Programme on Immunization: results from five randomised controlled trials.
Crawley J; Sismanidis C; Goodman T; Milligan P;
Lancet; 2012 Sep; 380(9846):1001-10. PubMed ID: 22850358
[TBL] [Abstract][Full Text] [Related]
5. Duration of protection against clinical malaria provided by three regimens of intermittent preventive treatment in Tanzanian infants.
Cairns M; Gosling R; Carneiro I; Gesase S; Mosha JF; Hashim R; Kaur H; Lemnge M; Mosha FW; Greenwood B; Chandramohan D
PLoS One; 2010 Mar; 5(3):e9467. PubMed ID: 20209126
[TBL] [Abstract][Full Text] [Related]
6. A randomized controlled trial of extended intermittent preventive antimalarial treatment in infants.
Kobbe R; Kreuzberg C; Adjei S; Thompson B; Langefeld I; Thompson PA; Abruquah HH; Kreuels B; Ayim M; Busch W; Marks F; Amoah K; Opoku E; Meyer CG; Adjei O; May J
Clin Infect Dis; 2007 Jul; 45(1):16-25. PubMed ID: 17554695
[TBL] [Abstract][Full Text] [Related]
7. Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania.
Mutabingwa T; Nzila A; Mberu E; Nduati E; Winstanley P; Hills E; Watkins W
Lancet; 2001 Oct; 358(9289):1218-23. PubMed ID: 11675058
[TBL] [Abstract][Full Text] [Related]
8. Comparison of chlorproguanil-dapsone with sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in young African children: double-blind randomised controlled trial.
Alloueche A; Bailey W; Barton S; Bwika J; Chimpeni P; Falade CO; Fehintola FA; Horton J; Jaffar S; Kanyok T; Kremsner PG; Kublin JG; Lang T; Missinou MA; Mkandala C; Oduola AM; Premji Z; Robertson L; Sowunmi A; Ward SA; Winstanley PA
Lancet; 2004 Jun; 363(9424):1843-8. PubMed ID: 15183620
[TBL] [Abstract][Full Text] [Related]
9. Randomised placebo-controlled trial of iron supplementation and malaria chemoprophylaxis for prevention of severe anaemia and malaria in Tanzanian infants.
Menendez C; Kahigwa E; Hirt R; Vounatsou P; Aponte JJ; Font F; Acosta CJ; Schellenberg DM; Galindo CM; Kimario J; Urassa H; Brabin B; Smith TA; Kitua AY; Tanner M; Alonso PL
Lancet; 1997 Sep; 350(9081):844-50. PubMed ID: 9310602
[TBL] [Abstract][Full Text] [Related]
10. Sulfadoxine-pyrimethamine, chlorproguanil-dapsone, or chloroquine for the treatment of Plasmodium vivax malaria in Afghanistan and Pakistan: a randomized controlled trial.
Leslie T; Mayan MI; Hasan MA; Safi MH; Klinkenberg E; Whitty CJ; Rowland M
JAMA; 2007 May; 297(20):2201-9. PubMed ID: 17519409
[TBL] [Abstract][Full Text] [Related]
11. Mefloquine for preventing malaria in pregnant women.
González R; Pons-Duran C; Piqueras M; Aponte JJ; Ter Kuile FO; Menéndez C
Cochrane Database Syst Rev; 2018 Mar; 3(3):CD011444. PubMed ID: 29561063
[TBL] [Abstract][Full Text] [Related]
12. Chlorproguanil-dapsone versus sulfadoxine-pyrimethamine for sequential episodes of uncomplicated falciparum malaria in Kenya and Malawi: a randomised clinical trial.
Sulo J; Chimpeni P; Hatcher J; Kublin JG; Plowe CV; Molyneux ME; Marsh K; Taylor TE; Watkins WM; Winstanley PA
Lancet; 2002 Oct; 360(9340):1136-43. PubMed ID: 12387962
[TBL] [Abstract][Full Text] [Related]
13. Intermittent treatment for malaria and anaemia control at time of routine vaccinations in Tanzanian infants: a randomised, placebo-controlled trial.
Schellenberg D; Menendez C; Kahigwa E; Aponte J; Vidal J; Tanner M; Mshinda H; Alonso P
Lancet; 2001 May; 357(9267):1471-7. PubMed ID: 11377597
[TBL] [Abstract][Full Text] [Related]
14. Mefloquine for preventing malaria in pregnant women.
González R; Pons-Duran C; Piqueras M; Aponte JJ; Ter Kuile FO; Menéndez C
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD011444. PubMed ID: 30480761
[TBL] [Abstract][Full Text] [Related]
15. Fansimef for prophylaxis of malaria: a double-blind randomized placebo controlled trial.
Bunnag D; Malikul S; Chittamas S; Chindanond D; Harinasuta T; Fernex M; Mittelholzer ML; Kristiansen S; Sturchler D
Southeast Asian J Trop Med Public Health; 1992 Dec; 23(4):777-82. PubMed ID: 1298089
[TBL] [Abstract][Full Text] [Related]
16. Intermittent treatment for the prevention of malaria during pregnancy in Benin: a randomized, open-label equivalence trial comparing sulfadoxine-pyrimethamine with mefloquine.
Briand V; Bottero J; Noël H; Masse V; Cordel H; Guerra J; Kossou H; Fayomi B; Ayemonna P; Fievet N; Massougbodji A; Cot M
J Infect Dis; 2009 Sep; 200(6):991-1001. PubMed ID: 19656069
[TBL] [Abstract][Full Text] [Related]
17. Molecular markers of resistance to sulfadoxine-pyrimethamine during intermittent preventive treatment for malaria in Mozambican infants.
Mayor A; Serra-Casas E; Sanz S; Aponte JJ; Macete E; Mandomando I; Puyol L; Berzosa P; Dobaño C; Aide P; Sacarlal J; Benito A; Alonso P; Menéndez C
J Infect Dis; 2008 Jun; 197(12):1737-42. PubMed ID: 18419347
[TBL] [Abstract][Full Text] [Related]
18. Chlorproguanil-dapsone: effective treatment for uncomplicated falciparum malaria.
Amukoye E; Winstanley PA; Watkins WM; Snow RW; Hatcher J; Mosobo M; Ngumbao E; Lowe B; Ton M; Minyiri G; Marsh K
Antimicrob Agents Chemother; 1997 Oct; 41(10):2261-4. PubMed ID: 9333058
[TBL] [Abstract][Full Text] [Related]
19. Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana.
Chandramohan D; Owusu-Agyei S; Carneiro I; Awine T; Amponsa-Achiano K; Mensah N; Jaffar S; Baiden R; Hodgson A; Binka F; Greenwood B
BMJ; 2005 Oct; 331(7519):727-33. PubMed ID: 16195288
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trial.
von Seidlein L; Milligan P; Pinder M; Bojang K; Anyalebechi C; Gosling R; Coleman R; Ude JI; Sadiq A; Duraisingh M; Warhurst D; Alloueche A; Targett G; McAdam K; Greenwood B; Walraven G; Olliaro P; Doherty T
Lancet; 2000 Jan; 355(9201):352-7. PubMed ID: 10665554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
